Merck & Co., Inc. (MRK) NYSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 263.36B |
| Enterprise Value | 299.33B |
| P/E Ratio | 145.48 |
| PEG Ratio | -1.67 |
| Price/Sales Ratio | 5.28 |
| Price/Book Ratio | 7.93 |
| Enterprise/Revenue | 5.93 |
| Enterprise/EBITDA | 33.82 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.04 |
| Operating Margin | 0.14 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.05 |
Income Statement
| Revenue | 64.93B |
| Revenue/Share | 27.24 |
| Gross Profit | 46.73B |
| EBITDA | 28.26B |
| Net Income | 18.25B |
| Diluted EPS | 7.28 |
Balance Sheet
| Total Cash | 9.65B |
| Total Cash/Share | 3.91 |
| Total Debt | 53.78B |
| Total Debt/Equity | 1.2 |
| Current Ratio | 1.35 |
| Book Value Per Share | 18.19 |
Price History
| 52-Week Change | 55.1 |
| 52-Week High | 156.92 |
| 52-Week Low | 92.11 |
| Moving Average 50 Days | 146.02 |
| Moving Average 200 Days | 128.82 |
Statistics
| Average Volume | 10.27M |
| Shares Outstanding | 2.47B |
| % Held by Institutions | 77.83 |
Dividend And Splits
| Trailing Annual Dividend Rate | 3.4 |
| Trailing Annual Dividend Yield | 2.36 |
| Payout Ratio | 3.41 |
| Last Split Factor | 131:125 |
| Last Split Date | June 03, 2021 |
AD